# Clearmind Medicine Inc. — Form D

Clearmind Medicine Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-07. The offering totals $2.4M, of which $2.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-02-07
- Form: D
- Accession: 0001213900-24-010974
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.4M
- Amount sold: $2.4M
- Investors: 12
- Date of first sale: 2024-01-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-504615

## Issuer

- Name: Clearmind Medicine Inc.
- CIK: 0001892500
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 101 - 1220 WEST 6TH AVENUE, VANCOUVER, A1, V6H1A5
- Phone: 973.536.1016

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Oz Adler | Director | Givatayim, L3 |
| Asaf Itzhaik | Director | Raanana, L3 |
| Yehonatan Shachar | Director | Vancouver, A1 |
| Amitay Weiss | Director | Bnei Brak, L3 |
| Prof. Mark Haden | Executive Officer | Vancouver, A1 |
| Alan Rootenberg | Executive Officer | Vancouver, A1 |
| Dr. Adi Zuloff-Shani | Executive Officer | Tel Aviv, L3 |

## More

- [CIK 1892500 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1892500&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001213900-24-010974.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.